Etoposide/irinotecanLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-24995-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：259 / 259

相关论文

共 50 条

[1] Camrelizumab/etoposide/irinotecanLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1975 (1) : 93 - 93
[2] Carboplatin/etoposide-phosphate/irinotecanLack of efficacy and haematological toxicity: case report
Reactions Weekly, 2024, 2027 (1) : 116 - 116
[3] Bevacizumab/IrinotecanLack of efficacy: case report
Reactions Weekly, 2024, 2024 (1) : 91 - 91
[4] Carboplatin/etoposide/irinotecanLack of efficacy and death: 2 case reports
Reactions Weekly, 2022, 1910 (1) : 124 - 124
[5] Carboplatin/irinotecanLack of efficacy: case report
Reactions Weekly, 2021, 1866 (1) : 114 - 114
[6] Cisplatin/irinotecanLack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 146 - 146
[7] Fluorouracil/Folinic-acid/IrinotecanLack of efficacy: case report
Reactions Weekly, 2025, 2043 (1) : 169 - 169
[8] Bevacizumab/capecitabine/irinotecanLack of efficacy in metastatic rectal adenocarcinoma: case report
Reactions Weekly, 2021, 1851 (1) : 82 - 82
[9] Etoposide/ImmunotherapiesLack of efficacy: case report
Reactions Weekly, 2025, 2043 (1) : 164 - 164
[10] Etoposide/immunoglobulinsLack of efficacy: case report
Reactions Weekly, 2025, 2054 (1) : 170 - 170

← 1 2 3 4 5 →